Synmosa Biopharma Plans To Acquire Up To 30% Stake Of Genovate Biotechnology

Synmosa Biopharma 4114:

• PLANS TO ACQUIRE UP TO 34.466 MILLION SHARES, OR 30% STAKE, OF GENOVATE BIOTECHNOLOGY 4130 BIDDING T$24 ($0.8) PER SHARE IN TAIWAN STOCK MARKET

• PLANS TO BID FOR THE GENOVATE SHARES FROM SEPT 17 TO OCT 7

• PLAN TO ACQUIRE THE STAKE IN GENOVATE AIMS TO SHARE RESOURCES, CREATE SCALE EFFICIENCY